AAN 2024: Prasinezumab may slow Parkinson’s symptom progression
Treatment with prasinezumab — an experimental therapy designed to stop toxic alpha-synuclein protein clumps from spreading through the brain —…
Articles by Marisa Wexler, MS
AAN 2024: Skin biopsy test may help confirm Parkinson’s diagnosis
The Syn-One test, which uses a skin biopsy to look for atypical clumps of the protein alpha-synuclein, may help both…
AAN 2024: AskBio’s gene therapy seen to ease motor symptoms
AB-1005, an experimental gene therapy administered directly into the brain, helped ease motor symptoms in patients with moderate…
Transplanting mitochondria shows promise in lab models of Parkinson’s
A new treatment that delivers healthy mitochondria to damaged nerve cells showed promise in cell and animal models of…
Machine learning tool may help detect Parkinson’s disease: Study
A new machine learning model is able to identify Parkinson’s disease more accurately than other models based on electroencephalography…
Anxiety is common in Parkinson’s, linked to worse life quality: Study
Anxiety is common among people with Parkinson’s disease and contributes to a worse life quality for patients irrespective of…
FDA says it needs more info on SPN-830 before decision on device
The U.S. Food and Drug Administration (FDA) said it needs more information before deciding whether to approve the apomorphine infusion…
Diabetes med lixisenatide may slow motor decline in Parkinson’s: Study
Treatment with lixisenatide, a medication approved for type 2 diabetes, significantly slowed the progression of motor symptoms in people with…
Powerful MRI scanner opens ‘whole new world’ in brain imaging
Scientists at the French Alternative Energies and Atomic Energy Commission (CEA) released the first images of a live human brain…
Mitochondrial DNA damage evident before Parkinson’s: Study
People with REM sleep behavior disorder, a condition that often precedes Parkinson’s disease, frequently have mitochondrial DNA (mtDNA) damage,…